You are hereBiblio / Science, Bioethics, and the Public Interest : On the Need for Transparency
Science, Bioethics, and the Public Interest : On the Need for Transparency
| Title | Science, Bioethics, and the Public Interest : On the Need for Transparency |
| Publication Type | Journal Article |
| Year of Publication | 2002 |
| Authors | Sharpe, Virginia A. |
| Journal | Hastings Center Report |
| Volume | 32 |
| Issue | 3 |
| Pagination | 23-26 |
| Type of Article | Article |
| Publication Language | eng |
| ISSN Number | 00930334 |
| Accession Number | 6818416 |
| Keywords | BIOETHICS , Clinical , Pharmaceutical , United |
| Abstract | Reveals that a body of evidence indicated that the pharmaceutical industry's gifts and inducements bias clinician judgment. Significance of the 1980 Bayh-Dole Act in the U.S.; Examples of financial inducements; Percentage of funding for clinical drug trials that come from the industry; Views of bioethicists on full transparency. |
| Notes | Sharpe, Virginia A.; Source Info: May/Jun2002, Vol. 32 Issue 3, p23; Subject Term: PHARMACEUTICAL industry; Subject Term: CLINICAL trials; Subject Term: BIOETHICS; Subject Term: UNITED States; NAICS/Industry Codes: 325412 Pharmaceutical Preparation Manufacturing; Number of Pages: 4p; Document Type: Article |
